Project Leader in Healthcare, Boston Consulting Group
Nikola has extensive knowledge of the Biopharma and MedTech industry. His project experience spans doing company/asset valuations, developing growth, M&A and market entry strategies, and applying Data & Analytics in Biopharma R&D and Commercial settings.
Nikola has a PhD in Molecular Biology and Biochemistry from the MRC Laboratory of Molecular Biology (LMB) at the University of Cambridge. He also has experience in genomics and stem cell biology from research placements in Switzerland and the UK. He has published a first co-author paper in Molecular Cell identifying a ubiquitin ligase as a potential drug target in Wnt Signalling and a paper in Breast Cancer on the stem cell hierarchy of the human mammary gland.
He was educated in Egypt, Serbia, Switzerland and Britain.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557